First-pass extracted concept

optogenetically engineered bacteria

Candidate: concept label1 source documents6 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

In this review, we highlight the latest advancements in the optogenetic engineering of bacteria for light-controlled disease theranostics and therapeutic regulation.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review2025Journal of Controlled ReleaseDOI PubMed

1 evidence snippet 6 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1advantagesupports2025Source 1DOI PubMed

Optogenetics offers remote controllability, non-invasiveness, and precise spatiotemporal control for regulating engineered bacteria.

Claim 2application scopesupports2025Source 1DOI PubMed

The review highlights biomedical applications of optogenetically engineered bacteria in cancer, intestinal inflammation, and systemic disease regulation.

Claim 3functional capabilitysupports2025Source 1DOI PubMed

Optogenetic tools can finely regulate engineered bacterial behavior to enable on-demand control of the dosage and location of therapeutic products.

Claim 4future directionsupports2025Source 1DOI PubMed

Improving the safety and efficacy of light-controlled bacterial therapies is presented as a key challenge and future direction.

Claim 5limitationsupports2025Source 1DOI PubMed

Clinical application of engineered bacteria is limited by differences in expression levels in patients and possible off-targeting.

Claim 6scopesupports2025Source 1DOI PubMed

Bacterial optogenetic systems in the review are categorized by photosensitive protein responses to blue, green, and red light.